proactiveinvestors.com
Zelira secures transformative US$33 million funding for HOPE® 1 autism program
Zelira Therapeutics Ltd (ASX:ZLD, OTCQB:ZLDAF) has secured a major funding milestone after its HOPE® 1 special purpose vehicle (SPV) signed definitive...